Loading organizations...
SOFIE develops and delivers molecular diagnostics and therapeutics, known as theranostics, primarily utilizing radiopharmaceuticals for Positron Emission Tomography (PET) imaging. The company focuses on creating advanced imaging agents, such as FAPI, and operates a robust network for the manufacturing and distribution of these specialized products. Its capabilities extend to contract manufacturing services, supporting the broader development and application of next-generation radiopharmaceuticals.
The company was founded in 2008 by a team that includes Johannes Czernin, Michael Phelps, and Owen Witte. Michael Phelps, notably a co-inventor of the PET scanner, brought significant expertise to the endeavor. The foundational insight stemmed from a collective aspiration to broaden the accessibility and application of PET products, ensuring more patients could benefit from advanced molecular imaging and therapeutic solutions.
SOFIE serves medical professionals, radiopharmacies, and the academic research community by providing critical tools for diagnosing and treating illnesses. Its overarching vision is to improve patient outcomes through the continuous development and reliable delivery of molecular diagnostics and therapeutics. The company remains committed to realizing the full potential of radiopharmaceuticals in clinical practice, advancing precision medicine.
Sofie Labs is an early-stage Silicon Valley startup building an AI-first, autonomous-agent CRM that automates inbound lead engagement and the SDR (sales development representative) layer of B2B sales, aiming to increase response speed, qualify leads, and set meetings with minimal human intervention[2][1].
High-Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick take: Sofie Labs is an early but well‑positioned entrant in AI‑driven sales automation—its promise is a scalable, always‑on autonomous SDR that fixes a persistent go‑to‑market bottleneck, but its impact will hinge on execution, measurable ROI in pilots, and integration with established CRM ecosystems[1][2][3][7].